Peripheral Neuropathy Trial, Recruiting NCT07356102 Sponsor: Ankara City Hospital Bilkent Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07356102
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with pudendal neuralgia using a specific set of recognised diagnostic guidelines called the Nantes criteria
  • People who are currently being seen at a Pain Medicine outpatient clinic
  • People whose pudendal neuralgia has been long-lasting and has not responded to standard treatments, or who cannot tolerate those treatments
  • People who are either not taking any medications for nerve pain, or who have been on a steady, unchanged dose of such medications for at least 3 months before joining
  • People who are able to attend all required study appointments and follow through with the study procedures
  • People who are able to understand the study information and agree in writing to take part

Who may not be able to join:

  • People who have a physical condition in the pelvic area that could be causing the pudendal pain (other than nerve-related causes)
  • People whose pain is only felt in the tailbone, buttock, or lower abdominal areas
  • People whose pain occurs only in sudden, brief bursts, or who have only itching, or whose medical scans fully account for all their symptoms
  • People with a personal history of cancer or an autoimmune disease
  • People who have had surgery in the past that may have changed the structure of the area around the pudendal nerve
  • People who are pregnant or who may be pregnant
  • People who have a cardiac pacemaker or any other implanted electrical device in their body
  • People who are taking blood-thinning medications or who have a clotting disorder that cannot be corrected
  • People who have an active infection anywhere in the body, or an infection at the site where the procedure would be performed
  • People with a known allergy or sensitivity to metals
  • People who are unable or unwilling to provide written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905333316636

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara City Hospital Bilkent
Registry
ClinicalTrials.gov
Start date
19 February 2025
Est. completion
1 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change in Pain Intensity Assessed by Numeric Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov